Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Radiation Treatment for Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT05415696
What this trial is testing

Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Who this might be right for
Prostate Cancer
Stanford University
Testing effectiveness (Phase 2)Looking for participantsNCT06369246
What this trial is testing

PRORAD-5 PROstate RADiation in 5 Fractions: Phase II Five Fraction Radiotherapy for Patients With Advanced Prostate Cancer.

Who this might be right for
Advanced Prostate Cancer
M.D. Anderson Cancer Center 100
Testing effectiveness (Phase 2)Study completedNCT00750269
What this trial is testing

Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT05722288
What this trial is testing

Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers

Who this might be right for
Localized Prostate CarcinomaLocally Advanced Cervical CarcinomaLocally Advanced Rectal Carcinoma+15 more
City of Hope Medical Center 49
Not applicableLooking for participantsNCT04534127
What this trial is testing

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia

Who this might be right for
Skin CancerMucosal Neoplasm of Oral CavitySoft Tissue Neoplasm
Alpha Tau Medical LTD. 56
Testing effectiveness (Phase 2)Ended earlyNCT04936841
What this trial is testing

Bempegaldesleukin (NKTR-214) With Radiation and Anti-PD-1 Immunotherapy for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Cancer
University of Wisconsin, Madison 5
Not applicableNot Yet RecruitingNCT05802654
What this trial is testing

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer

Who this might be right for
Early Lung CancerStereotactic Body Radiotherapy
Peking University Third Hospital 100
Early research (Phase 1)Study completedNCT03514069
What this trial is testing

Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

Who this might be right for
GliomaGlioblastoma
Case Comprehensive Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT03702179
What this trial is testing

Durvalumab Plus Tremelimumab With Concurrent Radiotherapy for Localized Muscle Invasive Bladder Cancer Treated With a Selective Bladder Preservation Approach

Who this might be right for
Invasive Bladder Cancer
Spanish Oncology Genito-Urinary Group 32
Testing effectiveness (Phase 2)Study completedNCT04249362
What this trial is testing

Study of Durvalumab Following Radiation Therapy in Patients With Stage 3 Unresectable NSCLC Ineligible for Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 102
Not applicableLooking for participantsNCT06287788
What this trial is testing

A Mucosal Contouring Method Based on Swallowing-induced Breakthrough Pain for Radiation-induced Oropharyngeal Mucositis

Who this might be right for
Radiation-induced Oropharyngeal MucositisSwallowing-induced Breakthrough Pain
Nanfang Hospital, Southern Medical University 240
Large-scale testing (Phase 3)Looking for participantsNCT07022483
What this trial is testing

Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer

Who this might be right for
Endometrial Cancer
Daiichi Sankyo 710
Not applicableLooking for participantsNCT05505188
What this trial is testing

Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

Who this might be right for
Neuropathic PainAnxiety Disorder/Anxiety StatePain, Chronic+5 more
University Hospital, Caen 120
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableStudy completedNCT03461341
What this trial is testing

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic CancerRecurrent Esophageal Cancer+4 more
St. James's Hospital, Ireland 3,000
Testing effectiveness (Phase 2)UnknownNCT01180504
What this trial is testing

Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer

Who this might be right for
Ovarian CancerTubal CarcinomaPrimary Peritoneal Carcinoma
University Hospital Heidelberg 36
Testing effectiveness (Phase 2)WithdrawnNCT01019278
What this trial is testing

Proton Beam Radiation Therapy and Cisplatin in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer and Positive Lymph Nodes

Who this might be right for
Cervical CancerStage IB Cervical CancerStage IIA Cervical Cancer+3 more
Abramson Cancer Center at Penn Medicine
Testing effectiveness (Phase 2)UnknownNCT05603013
What this trial is testing

Vinorelbine Metronomic Chemotherapy Combined With Hypofractionated Radiotherapy, PD-1/PD-L1 Sequential GM-CSF and IL-2 for Treatment of Advanced Refractory Non-small Cell Lung Cancer and Breast Cancer(PRaG 6.0)

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma Breast
Second Affiliated Hospital of Soochow University 45
Testing effectiveness (Phase 2)Looking for participantsNCT07544784
What this trial is testing

AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

Who this might be right for
Colorectal Cancer Liver Metastases (CRLM)
Fudan University 73
Not applicableLooking for participantsNCT07249333
What this trial is testing

Perioperative Complications After Neoadjuvant Radiotherapy for Colorectal Cancer

Who this might be right for
Colorectal CancerNeoadjuvant RadiotherapyPerioperative Complication
Oncology Institute of Vojvodina 80
Next Page